MedPath

A Prospective Single-Center Observational study of the Safety and Performance of the Vessel Sealing System (LigaSure) in a Pulmonary Resectio

Not Applicable
Conditions
ung cancer
Registration Number
JPRN-UMIN000008301
Lead Sponsor
First Department of Surgery, Tokyo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with a history of chest injury or pulmonary lobectomy 2)Patients with non-curative resectable factors of pulmonary cancer such as pleural dissemination and malignant pleural effusion on opening the chest 3)Patients with active bacterial and/or fungal infections 4)Patients receiving continued systemic (oral or intravenous) steroids 5)Patients with uncontrolled diabetes mellitus (HbA1c > 8.0%) 6)Patients with impaired major organ function (CTCAE ver. 4.0 Grade ≥ 2) 7)Patients with a psychiatric disorder or psychiatric symptoms that would preclude participation in the study 8)Any other patients judged by the doctor in charge to be ineligible as subjects in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The success rate and results of sealing of pulmonary arteries (under 5 mm in diameter)
Secondary Outcome Measures
NameTimeMethod
The frequency of additional procedures to the sealed sites during surgery. The occurrence frequency of intraoperative and postoperative adverse events, the duration of drain placement, and the duration of hospitalization.
© Copyright 2025. All Rights Reserved by MedPath